Saturday, November 17, 2018 12:32:54 PM
Both of the above statements are incorrect, Please see the full documents in the links provided.
RE: CBD approval, unfortunately the FDA approved one drug, not the component CBD
The FDA has advised in the past that CBD be taken off the controlled substance list, but the DEA has not acted on it. A different topic, but...
The FDA approved Epidiolex, period.
Statement by FDA Commissioner Scott Gottlieb on 06/25/18,
"But it’s also important to note that this is not an approval of marijuana or all of its components. This is the approval of one specific CBD medication for a specific use"
https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm611047.htm
The FDA approved the drug, not CBD
The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome.
https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm611046.htm
RE: Content of THC in hemp CBD os less than 0.3% THC (industrial)
Currently, CBD is still considered a Schedule I drug, but the farm bill will legalize CBD, in my opinion, by the changes being made in the 2018 farm bill with specific definitions of legal hemp. The DEA, IMO, will follow suit.
https://www.govtrack.us/congress/bills/115/s2667/text
SEC. 297A.Definitions
In this subtitle:
(1)Hemp
The term hemp means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis.
...and...
Sec. 6.Conforming changes to Controlled Substances Act
(a)In general
Section 102(16) of the Controlled Substances Act (21 U.S.C. 802(16)) is amended—
(1)by striking (16) The and inserting (16)(A) Subject to subparagraph (B), the; and
(2)by striking Such term does not include the and inserting the following:
(B)The term marihuana does not include—
(i)hemp, as defined in section 297A of the Agricultural Marketing Act of 1946; or
(ii)the
.
(b)Tetrahydrocannabinol
Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (c)(17) by inserting after Tetrahydrocannabinols the following: , except for tetrahydrocannabinols in hemp (as defined under section 297A of the Agricultural Marketing Act of 1946).
Recent CVSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:54:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 01:28:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:10:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:36:49 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM